Massive Bio is a health-tech company transforming how cancer patients access clinical trials. Operating in 17 countries across North America, Europe, and LATAM, we use proprietary AI technology to match patients to the most appropriate clinical trials—regardless of location, income, or cancer type. We partner with pharmaceutical companies, CROs, and healthcare institutions to accelerate oncology trial enrollment, reduce dropout rates, and deliver real-world evidence. 💠…
Saved company profile
Historical company information from a saved The Jobs API profile (LinkedIn/Crunchbase fields). It is not live-verified; figures may have changed. Missing values remain unknown.
An AI-driven platform connecting cancer patients to bio-pharmaceutical clinical trials.
Full company description
Massive Bio is a health-tech company transforming how cancer patients access clinical trials.
Operating in 17 countries across North America, Europe, and LATAM, we use proprietary AI technology to match patients to the most appropriate clinical trials—regardless of location, income, or cancer type.
We partner with pharmaceutical companies, CROs, and healthcare institutions to accelerate oncology trial enrollment, reduce dropout rates, and deliver real-world evidence.
💠 200K+ patients onboarded
💠 60+ pharma and CRO customers
💠 130+ strategic partners
💠 Founding member of CancerX & participant in the White House Cancer Moonshot
Explore how we simplify trial access and optimize recruitment across the oncology ecosystem.
🔗 Learn more: www.massivebio.com
Massive Bio was named after three converging revolutions: massive parallel sequencing, massive parallel computing, and the emerging ability to engineer biology itself. We started with symbolic AI before it was fashionable, and evolved into neurosymbolic systems that orchestrate data, computation, and biology—at scale—to bring precision oncology to patients.
LinkedIn followers
46,360
People associated on LinkedIn
104
Reported office locations
Istanbul, TR
Business categories
Health Care
Oncology
Biotechnology
Natural Language Processing
Medical
Artificial Intelligence (AI)
Big Data
Machine Learning
Pharmaceutical
Therapeutics
Other recorded names
Massive Bio
Massive Bio, Inc.
Product
Specialties
Targeted cancer therapies
Cancer genomics
Tumor profiling technologies
Clinical trial selection
Second Opinion
Cancer Treatment
precision oncology
personalized cancer treatment options
Oncology
Cancer Care
Cancer Research
Artificial Intelligence
Machine Learning
Data Analytics
and Patient Support
Profile identifies a recruitment agency
No
Reported total investment
23,817,500
Currency and observation date were not supplied; this is not a current valuation or a funding round.
Industry
Hospitals and Health Care
Size
51-200 employees
Headquarters
Istanbul
Organization type
Privately Held
Year founded
2014
Specialties
Targeted cancer therapiesCancer genomicsTumor profiling technologiesClinical trial selectionSecond OpinionCancer Treatmentprecision oncologypersonalized cancer treatment optionsOncologyCancer Care
Massive Bio has 1 open jobs in Canada as of November 6, 2026. Top locations: Québec.
Massive Bio: Massive Bio is a health-tech company transforming how cancer patients access clinical trials.
3+ YOECandidates need a life sciences, public health or healthcare-related bachelor's degree and at least 3 years of field-based provider relations or sales experience, ideally in oncology or hematology. An existing professional network among Canadian oncology providers, legal work authorization in Canada, and CRM comfort are required.